DOJ's Generic Drug Criminal Probe Snares Ex-Sandoz Exec
The U.S. Department of Justice signaled a major escalation Friday in its ongoing criminal probe of price-fixing among generic drug companies, announcing the guilty plea of a former Sandoz executive in the first...To view the full article, register now.
Already a subscriber? Click here to view full article